- Home
- ZYME vs GTY Comparison
ZYME vs GTY Comparison
Compare ZYME & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | GTY |
|---|---|---|
| Founded | 2003 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2022 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ZYME | GTY |
|---|---|---|
| Price | $26.76 | $32.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $38.90 | $32.60 |
| AVG Volume (30 Days) | ★ 517.9K | 339.4K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.92% |
| EPS Growth | ★ 33.33 | 8.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | $105,965,000.00 | ★ $221,727,000.00 |
| Revenue This Year | $183.10 | $9.39 |
| Revenue Next Year | N/A | $7.83 |
| P/E Ratio | ★ N/A | $77.15 |
| Revenue Growth | ★ 38.87 | 9.02 |
| 52 Week Low | $10.89 | $25.39 |
| 52 Week High | $29.75 | $34.75 |
Technical Indicators
Market Signals| Indicator | ZYME | GTY |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 45.93 |
| Support Level | $22.28 | $31.56 |
| Resistance Level | $27.35 | $34.30 |
| Average True Range (ATR) | 1.03 | 0.70 |
| MACD | -0.23 | -0.14 |
| Stochastic Oscillator | 11.52 | 14.81 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About GTY Getty Realty Corporation
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.